• Policy
• HK Inno.N to distribute Tamiflu as Roche’s new partner
• by Lee, Tak-Sun Nov 18, 2024 05:49am

• Policy
• AZ’s Imjudo and Imfinzi both make reimbursement progress
• by Lee, Tak-Sun Nov 15, 2024 05:49am

• Policy
• NHIS-Roche enters pricing negotiations for Perjeta’s reimb
• by Lee, Tak-Sun Nov 12, 2024 05:50am

• Policy
• Drug switching for atopic dermatitis measure submitted
• by Lee, Tak-Sun Nov 7, 2024 05:47am

• Policy
• Novartis cuts price of Cosentyx after PVA negotiations
• by Lee, Tak-Sun Nov 7, 2024 05:46am

• Policy
• 'Eutropin·Biktarvy' price drop amid sales hike
• by Lee, Tak-Sun Nov 6, 2024 05:52am

• Policy
• How will the new drug review process change with fee hike?
• by Lee, Hye-Kyung Nov 6, 2024 05:52am

• Policy
• Reimb standards that prevent abuse of HA Eye Drops imminent
• by Lee, Tak-Sun Nov 5, 2024 05:45am

• Policy
• Anticipating reimb for DPP4·SGLT2 combination drugs
• by Lee, Jeong-Hwan Nov 1, 2024 05:51am

• Policy
• Hyundai withdraws application for Mifegymiso approval again
• by Lee, Hye-Kyung Nov 1, 2024 05:50am